Cancer Research UK Logo London Research Institute

News
LRI scientist clinches two Wellcome Image Awards
Moving images reveal secrets behind breast cancer spread
'Marker' molecule offers hope for liver cancer test
2008 LRI Annual Scientific Research Report published
LRI's Jesper Svejstrup achieves FRS honour
Cancer Research UK scientists elected to the Academy of Medical Sciences
Virus reveals secret to cancer spread
First immune 'danger receptor' found
Gene controller crucial for cancer spread
Caetano Reis e Sousa receives prestigious award
Scientists find DNA repair 'scissors' after 18 year hunt
Schulze and Sahai receive YIP 2008 award
Scientists discover 'protector of the genome'
Scientists identify new regulatory mechanism for cytokinesis
Holger Gerhardt awarded Lister Prize
New cancer vaccine target found
LRI Annual Research Report published
LRI scientist receives Royal Society award

LRI News

Virus reveals secret to cancer spread

4 March 2009

Colour coded movement of vaccinia induced actin tailsLondon Research Institute (LRI) scientists studying a virus have unveiled an important clue to understanding how cancer spreads. Their research is published in Nature* today (Wednesday).

They discovered that the dynamics of the protein N-WASP determines how fast the vaccina virus moves. The vaccinia virus was used as a vaccine to eradicate Smallpox.

The researchers hope that the mechanism used by this virus to move can be compared with cancer cells, and eventually help reveal how to slow down or stop the spread of cancer.

Dr Michael Way, lead author based at Cancer Research UK's London Research Institute, said: "We discovered that a faster turnover of N-WASP results in the virus moving more quickly. We think this is reflected in a faster growth rate of actin filaments - which are chains of the actin protein under the virus that help it jump from one cell to another.

"We hope our understanding of how this protein regulates actin filament growth will help researchers to understand how tumour cells spread as the signalling pathway this virus uses is similar to the one used by tumour cells to invade other parts of the tissue."

The movement of tumour cells from the primary tumour to other parts of the body is the main reason that cancer can be so difficult to treat. Preventing this is one of the major challenges for research.

Dr Lesley Walker, director of cancer information at Cancer Research UK, said: "The process of cancer cells breaking away from their tumour and spreading to other areas of the body is very complex. Understanding how this works can hopefully help us to develop more effective cancer treatments in the future."


Weisswange I, Newsome TP, Schleich S, Way M.The rate of N-WASP exchange limits the extent of ARP2/3-complex-dependent actin-based motility. Nature 2009; 458(7234): 87-91.

For the full press release and other Cancer Research UK news and press releases, see online News.

For more information on Michael Way and the Cell Motility Laboratory, see his research profile.

Print this page Print this page
Feedback Feedback


Page updated 06/03/2009

Access keys   Accessibility   Privacy   Terms & Conditions   Top of page

Cancer Research UK is a registered charity No.1089464.
Registered as a company limited by guarantee in England & Wales No. 4325234.
Registered address 61 Lincoln's Inn Fields, London, WC2A 3PX.